echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Shanghai announced the first batch of varieties applied to participate in MAH reform pilot

    Shanghai announced the first batch of varieties applied to participate in MAH reform pilot

    • Last Update: 2016-10-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: on the official website of Shanghai food and Drug Administration October 25, 2016, the official website of Shanghai food and Drug Administration released the announcement on the list of pilot varieties that Shanghai has applied to participate in the reform of drug listing permit holder system According to the announcement, as of September 30, 2016, 9 drug R & D institutions and 11 drug manufacturing enterprises have submitted 12 application materials to Shanghai food and drug administration to participate in the pilot reform of drug listing license holder system  
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.